# Study Evaluating the Effect of IMA-638 in Subjects With Persistent Asthma

> **NCT00425061** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 159 (actual)

## Conditions studied

- Asthma

## Interventions

- **BIOLOGICAL:** IMA-638
- **BIOLOGICAL:** IMA-638
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00425061
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2015-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00425061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00425061, "Study Evaluating the Effect of IMA-638 in Subjects With Persistent Asthma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00425061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*